Atai stock forecast.

According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …Vice President-Strategic Operations. The latest Atari stock prices, stock quotes, news, and PONGF history to help you invest and trade smarter.Dec 1, 2023 · See the latest ATAI Life Sciences NV stock price (ATAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.30. 3. 2023. ... Psychedelic Stocks' Promising Outlook For Investors - Psychedelics Exclusive ... atai Founder Reveals 14 Reasons To Remain Optimistic - TDR ...

Find real-time DNUT - Krispy Kreme Inc stock quotes, company profile, news and forecasts from CNN Business.

Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years.

The Compass Pathways PLC stock price fell by -6.05% on the last day (Monday, 27th Nov 2023) from $6.45 to $6.06. During the last trading day the stock fluctuated 13.20% from a day low at $5.80 to a day high of $6.56. The price has risen in 6 of the last 10 days and is up by 14.99% over the past 2 weeks. Volume has increased on …Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...Analyst Recommendations on Atai Life Sciences N.V. Berenberg Bank Adjusts Atai Life Sciences Price Target to $11 From $18, Maintains Buy Rating. Mar. 29. MT. Credit Suisse Lowers Atai Life Sciences' PT to $9 From $11, Updates Model After Announced Workforce Reduction; Keeps Outperform Rating. Mar. 07.Find real-time DNUT - Krispy Kreme Inc stock quotes, company profile, news and forecasts from CNN Business.

Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ...

Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...

View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.ATA Inc-China Net Income Forecast for 2023 - 2025 - 2030. In the last year, ATA Inc-China has seen a decline in its Net Income, from $-169.84M to $-167.81M – a 1.20% decrease. In the next year, analysts predict that Net Income will reach $-169.84M – an increase of 1.21%. For the next nine years, the forecast is for Net Income to grow by 0.80%.Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.Analyst Recommendations on Atai Life Sciences N.V. Berenberg Bank Adjusts Atai Life Sciences Price Target to $11 From $18, Maintains Buy Rating. Mar. 29. MT. Credit Suisse Lowers Atai Life Sciences' PT to $9 From $11, Updates Model After Announced Workforce Reduction; Keeps Outperform Rating. Mar. 07.ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ... According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …

LPTX Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Leap Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 249.65% change from the last price of $2.86.25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...LPTX Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Leap Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 249.65% change from the last price of $2.86.atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...Atai Life Sciences N.V. (ATAI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atai Life Sciences N.V. | Nasdaq: ...

STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CI

Atai tumbled 32% to $6.82 per share, extending Tuesday’s slide into a second day. The stock is down about 55% from its June initial public offering price of $15. “It is imperative for me to be ...ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary. Vice President-Strategic Operations. The latest Atari stock prices, stock quotes, news, and PONGF history to help you invest and trade smarter.Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.21. 6. 2023. ... Recent price, YTD Change, Market value (mil), Average price target, Implied ... ATAI Life Sciences / ATAI, 1.78, -31.2, 303.8, 12.30, 593. Caribou ...Atai Life Sciences (ATAI) Stock Forecast & Price Prediction. Estimation of the future price movement of Atai Life Sciences stock, based on various factors such as historical price …Web

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...

Atai Life Sciences ( ATAI) seems focused on structuring. Investors will want to see meaningful financial results that go beyond job cuts. The psychedelic drug boom may be taking off, but one ...

AI is a growth business. Total spending on AI systems is forecast to reach $97.9 billion in 2023, up from $37.5 billion in 2019. For the five-year period ending in 2023, the AI sector is predicted ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32. Some better-ranked stocks in the broader Medical space are Select Medical Holdings Corporation SEM, HCA Healthcare, Inc. HCA and Atai Life Sciences N.V. ATAI, each carrying a Zacks Rank #2 (Buy ...2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed …WebJul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Find the latest Atai Life Sciences N.V. (ATAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00 ...A list of all stock splits on the US stock market in 2023, including both regular (forward) and reverse splits.Instagram:https://instagram. bond brokerhome loans for single momsopen door stock forecastlondon stock exchange brokers 1.04%. $183.15M. AMAM | Complete Ambrx Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ATAI - ATAI Life Sciences NV Stock quote - CNNMoney.com Markets Tech Media Success Video ATAI Life Sciences NV (NASDAQ:ATAI) 1.07 Delayed Data As of 3:58pm ET -0.055 / -4.91% Today’s... ai optionstock upgrades today SVRA Stock 12 Months Forecast. $6.67. (79.30% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Savara in the last 3 months. The average price target is $6.67 with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 79.30% change from the last price of $3.72.From July 11 to July 13, Wood purchased 947,340 shares of BFLY stock. 5. ATAI Life Sciences (ATAI) ... Stocks to Buy AMZN Stock Forecast: Predicting Amazon’s Performance in 2023 and Beyond how to buy stock on td ameritrade Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.Atai Life Sciences (ATAI) Stock Forecast & Price Prediction. Estimation of the future price movement of Atai Life Sciences stock, based on various factors such as historical price …Web